PharmFrame receives 300,000 requests per day

PharmFrame is the flagship product of B3-MED, a company that provides a system for supporting medical decision-making and automating the analysis and procurement of medicines.

In January, the B3-MED team expanded the integration of PharmFrame to new medical organizations in Russia. As a result, the system now receives more than 300,000 requests from medical professionals every day.

PharmFrame helps doctors quickly assess the safety of drug prescriptions, taking into account the patient's characteristics in terms of 15 potential risks:

• Risks of interaction between prescribed drugs.
• Risks of interaction between prescribed drugs and food.
• Risks of interaction between prescribed drugs and alcohol.
• Risks of allergic reactions.
• Risks of repeated therapy due to polypharmacy.
• Risks associated with the patient's age.
• Risks associated with the patient's gender.
• Risks of using medications while breastfeeding.
• Risks of using drugs during pregnancy.
• Risks of using drugs with concomitant diseases.
• Risks of using drugs while driving.
• Risks of prescribing drugs in overdose.
• Risks of prescribing drugs without proven efficacy.
• Risks of prescribing drugs not included in Russian clinical guidelines.
• Risk of exceeding the duration of drug use recommended in Russian clinical guidelines and/or drug instructions.

PharmFrame allows the administrations of medical organizations to spend funds more efficiently on the purchase of drugs, including giving preference to the most important drugs and reducing costs for drugs without proven effectiveness.

Thus, thanks to the PharmFrame system, medical organizations increase the safety of the medical care they provide.